Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges (2008) - Drugs Forum
Drugs-Forum  
News Groups Blog Forum Chat Video Audio Images Documents Wiki Home
Go Back   Drugs Forum > CHEMICAL & (SEMI-) SYNTHETIC DRUGS > Ecstasy (MDMA, MDEA, MDA)
Register Tags Mark Forums Read

Notices

Ecstasy (MDMA, MDEA, MDA) Ecstasy (XTC) pills and pure MDMA

Reply
 
Thread Tools Display Modes
  #1  
Old 20-03-2008, 08:17
Jatelka's Avatar
Jatelka Jatelka is offline
Jatelka is back in a funk: The weekend aint so great!
Psychedelic Shepherdess
Moderator
 
Join Date: 16-10-2005
Location: United Kingdom
Age: 33
Posts: 5,025
Jatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond repute
Points: 18,048, Level: 19 Points: 18,048, Level: 19 Points: 18,048, Level: 19
Activity: 46% Activity: 46% Activity: 46%
Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges (2008)

A new entry has been added to Drugs Archive

Description:
Neuroscience e-published January 12 2008

Baumann MH, Clark RD, Franken FH, Rutter JJ, Rothman RB

3,4-Methylenedioxymethamphetamine (MDMA or ecstasy) stimulates the transporter-mediated release of monoamines, including 5-HT. High-dose exposure to MDMA causes persistent 5-HT deficits (e.g. depletion of brain 5-HT) in animals, yet the functional and clinical relevance of such deficits are poorly defined. Here we examine functional consequences of MDMA-induced 5-HT depletions in rats. Male rats received binges of three i.p. injections of MDMA or saline, one injection every 2 h; MDMA was given at a threshold pharmacological dose (1.5 mg/kgx3, low dose) or at a fivefold higher amount (7.5 mg/kgx3, high dose). One week later, jugular catheters and intracerebral guide cannulae were implanted. Two weeks after binges, rats received acute i.v. challenge injections of 1 and 3 mg/kg MDMA. Neuroendocrine effects evoked by i.v. MDMA (prolactin and corticosterone secretion) were assessed via serial blood sampling, while neurochemical effects (5-HT and dopamine release) were assessed via microdialysis in brain. MDMA binges elevated core temperatures only in the high-dose group, with these same rats exhibiting approximately 50% loss of forebrain 5-HT 2 weeks later. Prior exposure to MDMA did not alter baseline plasma hormones or dialysate monoamines, and effects of i.v. MDMA were similar in saline and low-dose groups. By contrast, rats pretreated with high-dose MDMA displayed significant reductions in evoked hormone secretion and 5-HT release when challenged with i.v. MDMA. As tolerance developed only in rats exposed to high-dose binges, hyperthermia and 5-HT depletion are implicated in this phenomenon. Our results suggest that MDMA tolerance in humans may reflect 5-HT deficits which could contribute to further dose escalation

To check it out, rate it or add comments, visit Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges (2008)
The comments you make there will appear in the posts below.
Reply With Quote
Reply

Bookmarks

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Interesting scholarly drug facts rxbandit Pharmacology 17 30-10-2008 06:53
Effects - Hard to get high recently mrjmrj Cannabis using 14 06-03-2008 03:45
Health - high tolerence to zero tolerence!? hippie_lain Alcohol 1 31-12-2007 07:30


Sitelinks: Site Functions:

All times are GMT +1. The time now is 17:17.


Copyright: Substance Information Network 2003 - 2009, All rights reserved